Transdermal Drug Delivery: Global Markets

June 2021 | 109 pages | ID: TB23C2F8C826EN
BCC Research

Abstracts

Report Scope

This report aims to provide a comprehensive study of the global market for transdermal drug delivery technologies/systems. It provides a detailed description of the different types of transdermal drug delivery systems (passive and active) and the current and historical market revenues.

Transdermal drug delivery technologies/systems include passive transdermal drug delivery and active transdermal drug delivery. Passive transdermal drug delivery technologies/systems are segmented into matrix, reservoir and other transdermal drug delivery technologies/systems.

This report also offers a detailed study of therapeutic applications for transdermal drug delivery: pain, central nervous system (CNS) disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders and others. An in-depth analysis of the global market for transdermal drug delivery technologies/systems includes historical data and market projection of sales by technology/system type, therapeutic application, end-user and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors and respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technology/device market.

Report Includes

• 60 tables
• An overview of the global markets for transdermal drug delivery (TDD) technologies/systems within the pharmaceutical industry
• Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Market outlook and forecast trends of clinical application areas and end user segments of transdermal drug delivery technologies/systems
• Estimation of market size and revenue forecast for TDD market, and corresponding market share analysis by technology/system type, therapeutic application, end-user, and region
• Discussion of the key market dynamics (DROs), industry structure, regulatory approval, market deterrents, unmet needs and other factors driving opportunities in pharmaceutical research
• Review of patents, new developments and emerging technologies, clinical trials for many pipeline products, and potential markets for future developments
• Impact analysis of the Covid-19 pandemic on transdermal drug delivery systems market as against the overall pharmaceuticals industry
• Insight into recent industry activities, competitive landscape of the major players operating within the global market, and their corresponding company share analysis
• Profile descriptions of the leading drug delivery companies including AbbVie, Dr. Reddy's Laboratories Ltd., Bayer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Teva Pharmaceutical, and Viatris

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Scope of This Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND

Overview of Transdermal Drug Delivery Systems
Mechanism of Transdermal Drug Delivery
Advantages of Transdermal Drug Delivery
Disadvantages of Transdermal Drug Delivery
TDSS Types/Forms
Transdermal Patch
Transdermal Gel
Transdermal Spray
Transdermal Ointment
TDDS Technology Types
Passive TDDS
Types of Passive TDDS
Active TDDSs
Types of Active TDDS
Clinical Application of TDDS
Pain Management
CNS Disorders
Hormonal Applications
Smoking Cessation
Motion Sickness
Cardiovascular Diseases (CVD)
Others
End Users of TDDSs
Home Care Settings
Hospitals and Healthcare Clinics

CHAPTER 4 MARKET BREAKDOWN BY TECHNOLOGY TYPE

Global Market for TDDSs by Type
Passive TDDSs by Type
Passive TDDSs by Region
Active TDDSs by Region

CHAPTER 5 MARKET BREAKDOWN BY APPLICATION

Global Market for TDDS by Therapeutic Application
Market Size and Forecast by Therapeutic Application Type
Pain
CNS Disorders
Hormonal Applications
Smoking Cessation
Motion Sickness
CVD
Other Therapeutic Applications for TDDSs

CHAPTER 6 MARKET BREAKDOWN BY REGION

Global Markets for TDDSs by Region
North America
Europe
Asia-Pacific
RoW

CHAPTER 7 MARKET BREAKDOWN BY END USER

Global Markets for TDDS by End User
Market Size and Forecast by End User
North American End-User Market
European End-User Market
Asia-Pacific End-User Market
RoW

CHAPTER 8 NEW DEVELOPMENTS AND EMERGING TECHNOLOGIES

Innovative Transdermal Technologies
Technologies by Hisamitsu Pharmaceutical Co. Inc.
Technologies by 4 P Therapeutics (Nutriband)
Technologies by Corium Inc.
Technologies by Tapemark
Emerging Technologies and Applications for TDDS
Company/System

CHAPTER 9 MARKET DYNAMICS

Market Trends and Growth Drivers
Aging Population
Technology Innovations and New Product Development
Increasing Awareness
Large Unpenetrated Addressable Market
Market Restraining Factors
Product Development and Manufacturing Challenges
The Barrier Nature of the Skin
Side Effects
High Cost of Drug Development and Pricing Pressure
Market opportunity
Repositioning of Currently Marketed Products

CHAPTER 10 COMPETITIVE LANDSCAPE

Overview
Key Available TDDSs
Pain Management
Hormone Replacement Therapy
Female Contraception
CNS Disorders
Smoking Cessation
Motion Sickness
For Cardiovascular Diseases
Overactive Bladder
Other Applications
Global Market Shares of Leading Companies
Recent Industry Activities
Product Launches and Approvals
Agreements and Collaborations
Acquisitions and Mergers
Others

CHAPTER 11 IMPACT OF COVID-19 PANDEMIC

CHAPTER 12 COMPANY PROFILES

ABBVIE INC.
ACRUX LTD.
ALVOGEN
AMNEAL PHARMACEUTICALS INC.
BAYER HEALTHCARE PHARMACEUTICALS
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
DR. REDDY'S LABORATORIES LTD.
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
HISAMITSU PHARMACEUTICAL CO. INC.
JOHNSON & JOHNSON
KYOWA KIRIN CO. LTD.
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
NOVEN PHARMACEUTICALS INC.
PERRIGO COMPANY PLC
PURDUE PHARMA LP
TAPEMARK
TEVA PHARMACEUTICAL INDUSTRIES LTD.
UCB S.A.
USPHARMA LTD.
VERTICAL PHARMACEUTICALS LLC
VIATRIS INC.

CHAPTER 13 APPENDIX: ACRONYMS

List Of Tables

LIST OF TABLES

Summary Table: Global Market for Transdermal Drug Delivery Systems, by Type, Through 2026
Table 1: Difference Between Topical and Transdermal Drug Delivery Systems
Table 2: Currently Marketed Transdermal Drugs
Table 3: Classification of Transdermal Drugs for Pain Management
Table 4: OTC and Prescription Classifications
Table 5: Classification of Transdermal Drugs Used for CNS Disorders
Table 6: Classification of Transdermal Drugs Used for Motion Sickness
Table 7: Classification of Transdermal Drugs Used for CVD
Table 8: Classification of Transdermal Drugs for Other Applications
Table 9: Global Market for Transdermal Drug Delivery Systems, by Type, Through 2026
Table 10: Global Market for Passive Transdermal Drug Delivery Systems, by Type, Through 2026
Table 11: Global Market for Passive Transdermal Drug Delivery Systems, by Region, Through 2026
Table 12: Global Market for Active Transdermal Drug Delivery Systems, by Region, Through 2026
Table 13: Global Market for Transdermal Drug Delivery Systems, by Therapeutic Application, Through 2026
Table 14: Global Market for Transdermal Drug Delivery Systems for Pain Management, by Region, Through 2026
Table 15: Global Market for Transdermal Drug Delivery Systems Indicated for CNS Disorders, by Region, Through 2026
Table 16: Global Market for Transdermal Drug Delivery Systems for Hormonal Applications, by Region, Through 2026
Table 17: Global Market for Transdermal Drug Delivery Systems for Smoking Cessation, by Region, Through 2026
Table 18: Global Market for Transdermal Drug Delivery Systems for Motion Sickness, by Region, Through 2026
Table 19: Global Market for Transdermal Drug Delivery Systems for CVD, by Region, Through 2026
Table 20: Global Market for Transdermal Drug Delivery Systems for Other Therapeutic Applications, by Region, Through 2026
Table 21: Global Market for Transdermal Drug Delivery Systems, by Region, Through 2026
Table 22: Elder Population, Selected European Countries
Table 23: Global Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 24: North American Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 25: European Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 26: Asia-Pacific Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 27: RoW Market for Transdermal Drug Delivery Systems, by End User, Through 2026
Table 28: Industry-Funded Clinical Trials for Transdermal Drug Delivery Systems, 2021
Table 29: Total Elder Population, by Country, 2008 and 2018
Table 30: Key Manufacturers, Transdermal Drug Delivery Systems for Pain Management
Table 31: Key Manufacturers, Transdermal Drug Delivery Systems for Hormonal Replacement Therapy
Table 32: Key Manufacturers, Transdermal Drug Delivery Systems for Female Contraception
Table 33: Key Manufacturers of Transdermal Drug Delivery Systems for CNS Disorders
Table 34: Key Manufacturers of Transdermal Drug Delivery Systems for Smoking Cessation
Table 35: Key Manufacturers of Transdermal Drug Delivery Systems for Motion Sickness
Table 36: Key Manufacturers of Transdermal Drug Delivery Systems for CVD
Table 37: Key Manufacturers of Transdermal Drug Delivery Systems for Overactive Bladder
Table 38: Key Manufacturers of Transdermal Drug Delivery Systems for Other Applications
Table 39: Leading Company’s Share in Transdermal Drug Delivery Systems, 2020
Table 40: AbbVie Inc.: Transdermal Drug Delivery Product Portfolio
Table 41: Alvogen: Transdermal Drug Delivery Product Portfolio
Table 42: Amneal Pharmaceuticals Inc.: Transdermal Drug Delivery Product Portfolio
Table 43: Bayer Healthcare Pharmaceuticals: Transdermal Drug Delivery Product Portfolio
Table 44: Boehringer Ingelheim International GmbH: Transdermal Drug Delivery Product Portfolio
Table 45: Endo Pharmaceuticals Inc.: Transdermal Drug Delivery Product Portfolio
Table 46: GlaxoSmithKline PLC: Transdermal Drug Delivery Product Portfolio
Table 47: Hisamitsu Pharmaceutical Co. Inc.: Rx Product Portfolio
Table 48: Hisamitsu Pharmaceutical Co. Inc.:OTC Pain Relief Products
Table 49: Johnson & Johnson: Transdermal Drug Delivery Product Portfolio
Table 50: Kyowa Kirin Co. Ltd.: Transdermal Drug Delivery Product Portfolio
Table 51: Lavipharm: Transdermal Drug Delivery Product Portfolio
Table 52: Luye Pharma Group Ltd.: Transdermal Drug Delivery Product Portfolio
Table 53: Novartis AG: Transdermal Drug Delivery Product Portfolio
Table 54: Perrigo Company PLC.: Transdermal Drug Delivery Product Portfolio
Table 55: Purdue Pharma LP: Transdermal Drug Delivery Product Portfolio
Table 56: Teva Pharmaceutical Industries Ltd.: Transdermal Drug Delivery Product Portfolio
Table 57: UCB S.A.: Transdermal Drug Delivery Product Portfolio
Table 58: USpharma: Transdermal Drug Delivery Product Portfolio
Table 59: Viatris Inc.: Transdermal Drug Delivery Product Portfolio
Table 60: Acronyms Used in This Report

List Of Figures

LIST OF FIGURES

Summary Figure: Global Market for Transdermal Drug Delivery Systems, by Type, 2020-2026
Figure 1: Mechanism of Transdermal Drug Delivery System
Figure 2: Single Layer Drug in Adhesive Transdermal Delivery System
Figure 3: Multi-Layer Drug in Adhesive Transdermal Delivery System
Figure 4: Matrix Transdermal Delivery System
Figure 5: Reservoir Transdermal Delivery System
Figure 6: Global Market Shares of Transdermal Drug Delivery Systems, by Type, 2020
Figure 7: Global Market for Passive Transdermal Drug Delivery Systems, by Type, 2020
Figure 8: Global Market Shares of Passive Transdermal Drug Delivery Systems, by Region, 2020
Figure 9: Global Market Shares of ActiveTransdermal Drug Delivery Systems, by Region, 2020
Figure 10: Global Market Shares of Transdermal Drug Delivery Systems, by Therapeutic Application, 2020
Figure 11: Global Market Shares of Transdermal Drug Delivery Systems for Pain Management, by Region, 2020
Figure 12: Global Market for Transdermal Drug Delivery Systems Indicated for CNS Disorders, by Region, 2020
Figure 13: Global Market Shares of Transdermal Drug Delivery Systems for Hormonal Applications, by Region, 2020
Figure 14: Global Market Shares of Transdermal Drug Delivery Systems for Smoking Cessation, by Region, 2020
Figure 15: Global Market Shares of Transdermal Drug Delivery Systems for Motion Sickness, by Region, 2020
Figure 16: Global Market Shares of Transdermal Drug Delivery Systems for CVD, by Region, 2020
Figure 17: Global Market Shares of Transdermal Drug Delivery Systems for Other Therapeutic Applications, by Region, 2020
Figure 18: Global Market Shares of Transdermal Drug Delivery Systems, by Region, 2020
Figure 19: Global Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 20: North American Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 21: European Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 22: Asia-Pacific Market Shares of Transdermal Drug Delivery Systems, by End User, 2020
Figure 23: RoW Market Shares of Transdermal Drug Delivery Systems, by End User, 2020